Confirmed Keynotes Include:

"MedTech 2016: Key Trends and Technologies to Watch" by David Cassak & Stephen Levin
David Cassak
Managing Partner, Innovation In Medtech, LLC
Editor-in-Chief, The MedTech Strategist
David Cassak has more than 30 years of experience in the health care industry.  Prior to co-founding Innovation In Medtech, LLC, he served as Vice President, Content and Managing Director, Medical Devices for Elsevier Business Intelligence, A Reed Elsevier Company, now part of Informa Business Information, where he wrote extensively on the medical device industry for Windhover’s monthly publications, IN VIVO and START-UP.  He is also a frequent speaker before various companies and industry trade groups.
Prior to joining Elsevier, Cassak worked for nearly 20 years at Windhover Information Inc., a company he founded with his business partner, Roger Longman, which spun out the publications business of The Wilkerson Group, a leading management consulting firm at the time.  Long known for publishing IN VIVO, widely recognized as the premier provider of business intelligence in the health care industry, Windhover launched a number of other successful publications, including START-UP: Emerging Medical Ventures, and The RPM Report: Regulation • Policy • Market Access.  In 2004, Windhover acquired Medtech Insight, Inc., which published the MEDTECH INSIGHT: Medical Technology Market Intelligence newsletter.  While at Windhover/EBI, David also organized and produced numerous conferences around the world, including the Investment in Innovation (In3) medical device partnering conference series, as well as such pharma-focused conferences as Pharmaceutical Strategic Alliances, Euro-Biotech and BIO-Windhover.  In 2008, Windhover was acquired by Elsevier, which formed Elsevier Business Intelligence, combining the products of Windhover and F-D-C Reports, publishers of The Gray Sheet and The Pink Sheet, among other industry newsletters.
​Stephen Levin
Managing Partner, Innovation In Medtech, LLC
Editor-in-Chief, The MedTech Strategist
Prior to co-founding Innovation In Medtech, Stephen Levin served as Editor-in-Chief of Medical Devices for Elsevier Business Intelligence, where he directed the company’s editorial coverage of the medical device industry, following Elsevier’s acquisition of Windhover Information in 2008.  This included managing the device content for the following publications: IN VIVO, START-UP, MEDTECH INSIGHT, The Gray Sheet, and The Silver Sheet, along with the IN3 medical device partnering conference series.  Stephen joined Windhover Information in 1997, where as Executive Editor, he specialized in covering the device industry, distribution, and legal issues.  He also served as the company’s General Counsel.  He also formerly was an Editor of Health Industry Today, a leading publication in the health care industry.
Prior to joining Windhover, Stephen was Senior Counsel to the US Senate Permanent Subcommittee on Investigations, where he directed Senate investigations into a wide variety of areas including health care fraud and abuse, international organized crime, and corruption in federal contracting programs, while also participating in other Senate investigations including the Whitewater inquiry.  Before joining the Subcommittee, he was with the Federal Election Commission (enforcement and regulatory counsel) and the Department of Justice (international criminal law).


​​Confirmed Speakers & Chairs Include: 

  • Adelaide Cracco, Investment Manager, European Investment Fund
  • Alex Klim, Head of BD & Consulting, Clinical Trials Logistics & Packaging, DHL Clinical Supply
  • Anna Samanta, Managing Partner, Deloitte AG
  • Antje Niemeyer, IBM Watson Health Leader, DACH, IBM Deutschland GmbH
  • Beat Merz, Managing Director, Rockport Venture Partners
  • Benedikt Luhmann, Director, Monitor Deloitte Strategy
  • Colin Terry, Partner, R&D Strategy and Operations​, Deloitte AG
  • David Peoples, Executive Director, Healthcare Investment Banking, JP Morgan
  • Eduardo Margallo, Chief Executive Officer, MedLumics S.L.
  • Erich Wolff, Sr. Director, Corporate Development, Medtronic, Inc.
  • Francesca Wuttke, Managing Director/Investment Principal Europe, Merck Global Health Innovation Fund, LLC
  • Jennifer McMahon, Associate, Seroba Life Sciences
  • Justin Lynch, Partner & CFO, Fountain Healthcare Partners
  • Katrin Geyskens, Partner, Capricorn Venture Partners NV
  • Klaus Stoeckemann, Managing Partner, Peppermint Venture Partners GmbH
  • Klaus Lun, Vice President, Head of Corporate Development, Tecan
  • Martin Pfister, Senior Investment Manager, High-Tech Gruenderfonds Management GmbH
  • Martien van Osch, Managing Partner, Forbion Capital Partners
  • Maurizio PetitBon, General Partner, Kreos Capital
  • Min Sha, Global Head of M&A and Alliances, Roche Diagnostics
  • Nadir Ammour, Global Head, Patients & Partners Management, Sanofi
  • Peter Shone, Vice President - Engineering, Parexel
  • Phil Huber, Senior Director of Finance and Human Resources, Sequana Medical AG
  • Philipp Schneider, Director Digital Health Technologies, Sonova AG
  • ​Sam Gray, Partner, Apposite Capital
  • Tim Jessel, Manager, Life Sciences Strategy and Operations, Deloitte
  • Tim Keliher, Director of Pharmaceutical Sales, TriNetX, Inc.
  • Ulrich Muehlner, Founder & Managing Director, GrowthCube Partners LLC
  • Vishal Gulati, VC & Independent Board Director, Venture Partner, Draper Esprit LLP, Horizon Discovery Group PLC, Digital Health Forum
  • More TBA...